Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeev S Samant

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Molecular Cancer|January 18, 2007
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activationRajeev S Samant, David W Clark, Rebecca A Fillmore, et al.
International Journal of Cancer|November 18, 2003
Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12Erich B Jaeger, Marina A Chekmareva, Thelma R Tennant, et al.
The Journal of Biological Chemistry|January 24, 2008
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cellsDouglas R Hurst, Yi Xie, Kedar S Vaidya, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Scientific Reports|October 28, 2017
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer ModelKayla F Goliwas, Jillian R Richter, Hawley C Pruitt, et al.
Scientific Reports|January 24, 2017
Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signalingShamik Das, William P Jackson, Jeevan K Prasain, et al.
Biochemical and Biophysical Research Communications|August 22, 2006
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperoneDouglas R Hurst, Alka Mehta, Blake P Moore, et al.
Cell Death & Disease|March 5, 2021
Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancerShannon E Weeks, Sarah C Kammerud, Brandon J Metge, et al.
Cancer Letters|May 30, 2021
Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seedingHeba Allah M Alsheikh, Brandon J Metge, Chae-Myeong Ha, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of niclosamide on basal-like breast cancersAngelina I Londoño-Joshi, Rebecca C Arend, Laura Aristizabal, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Molecular Cancer|January 18, 2007
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activationRajeev S Samant, David W Clark, Rebecca A Fillmore, et al.
International Journal of Cancer|November 18, 2003
Inhibition of prostate cancer metastatic colonization by approximately 4.2 Mb of human chromosome 12Erich B Jaeger, Marina A Chekmareva, Thelma R Tennant, et al.
The Journal of Biological Chemistry|January 24, 2008
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cellsDouglas R Hurst, Yi Xie, Kedar S Vaidya, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Scientific Reports|October 28, 2017
Methods to Evaluate Cell Growth, Viability, and Response to Treatment in a Tissue Engineered Breast Cancer ModelKayla F Goliwas, Jillian R Richter, Hawley C Pruitt, et al.
Scientific Reports|January 24, 2017
Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signalingShamik Das, William P Jackson, Jeevan K Prasain, et al.
Biochemical and Biophysical Research Communications|August 22, 2006
Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperoneDouglas R Hurst, Alka Mehta, Blake P Moore, et al.
Cell Death & Disease|March 5, 2021
Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancerShannon E Weeks, Sarah C Kammerud, Brandon J Metge, et al.
Cancer Letters|May 30, 2021
Normalizing glucose levels reconfigures the mammary tumor immune and metabolic microenvironment and decreases metastatic seedingHeba Allah M Alsheikh, Brandon J Metge, Chae-Myeong Ha, et al.
Molecular Cancer Therapeutics|February 21, 2014
Effect of niclosamide on basal-like breast cancersAngelina I Londoño-Joshi, Rebecca C Arend, Laura Aristizabal, et al.
Pageof 9